Patents by Inventor Raphaël Ho Tsong Fang

Raphaël Ho Tsong Fang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic compounds comprising HIV GP41 peptide coupled to CRM197 carrier protein
    Patent number: 9511136
    Abstract: The present invention relates to the field of vaccines directed against viruses of the HIV family. More particularly, it relates to an immunogenic compound comprising a peptide of the following formula (I) NH2-[Nt]y-P-W-N-X-S-X2-S-N-X3-X4-X-X6-X7-I-W-[Ct]z-COOH (I) which is covalently linked to a carrier protein consisting of a CRM197 protein. It also concerns a composition containing this immunogenic compound and the uses of these immunogenic compounds and compositions for preventing and/or treating a condition caused by the infection of an individual with a HIV virus.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: December 6, 2016
    Assignee: INNAVIRVAX
    Inventors: Joël Crouzet, Raphaël Ho Tsong Fang, Dominique Desfontaines
  • IMMUNOGENIC COMPOUNDS COMPRISING HIV GP41 PEPTIDE COUPLED TO CRM197 CARRIER PROTEIN
    Publication number: 20150147348
    Abstract: The present invention relates to the field of vaccines directed against viruses of the HIV family. More particularly, it relates to an immunogenic compound comprising a peptide of the following formula (I) NH2-[Nt]y-P-W-N-X-S-X2-S-N-X3-X4-X-X6-X7-I-W-[Ct]z-COOH (I) which is covalently linked to a carrier protein consisting of a CRM197 protein. It also concerns a composition containing this immunogenic compound and the uses of these immunogenic compounds and compositions for preventing and/or treating a condition caused by the infection of an individual with a HIV virus.
    Type: Application
    Filed: May 30, 2013
    Publication date: May 28, 2015
    Inventors: Joël Crouzet, Raphaël Ho Tsong Fang, Dominique Desfontaines